WeVote
Log In

Bill

Bill

HB 1750

Medical marijuana; pregnant women; term; effective date.

2026 Regular Session Introduced by Anthony Moore

HB 1750 establishes medical marijuana access or restriction parameters for pregnant women in Oklahoma's medical cannabis program.

Second Reading referred to Rules
0
WeVote Research Nonpartisan
Bill Summary · HB 1750

Legislative bill overview

HB 1750 addresses the use of medical marijuana by pregnant women in Oklahoma. The bill modifies existing medical marijuana regulations to establish parameters around access, use, or restrictions for this population. The specific provisions and effective date are core elements of the legislation.

Why is this important

Medical marijuana policy for pregnant women involves competing public health considerations—potential therapeutic benefits against possible fetal risks. Oklahoma's approach will influence how the state balances patient autonomy with regulatory protections during pregnancy, potentially affecting healthcare provider guidance and pregnant patients' treatment options.

Potential points of contention

  • Fetal safety concerns: Medical and scientific communities have not reached consensus on marijuana's effects during pregnancy; some research suggests potential developmental risks while advocates cite therapeutic applications
  • Patient autonomy vs. paternalism: Disagreement over whether the state should restrict access to medical treatments for pregnant women or allow individual decision-making with physician consultation
  • Medical evidence standards: Questions about what level of scientific evidence should justify restrictions or permissions, given ongoing research limitations in this area

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.